Breaking News Instant updates and real-time market news.

CI

Cigna

$172.55

-3.5 (-1.99%)

, MOH

Molina Healthcare

$59.80

-2.52 (-4.04%)

08:52
08/05/17
08/05
08:52
08/05/17
08:52

Week in review: How Trump's policies moved stocks

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Trump and his administration with this weekly recap compiled by The Fly: 1. HEALTHCARE: Earlier this week, President Donald Trump threatened to end government payments to health insurers if Congress does not pass a new healthcare bill and goaded them to not abandon their seven-year quest to replace Obamacare, according to Reuters. In a Twitter message, Trump said "if a new HealthCare Bill is not approved quickly, BAILOUTS for Insurance Companies and BAILOUTS for Members of Congress will end very soon!" Meanwhile, Cigna (CI) CEO David Cordani noted on the company's conference call on Friday that the company still sees a loss from its Affordable Care Act individual business this year, though at a lower level than in 2016, and Molina Healthcare (MOH) announced that it plans to exit the Utah and Wisconsin ACA Marketplaces effective December 31, 2017. Other publicly traded companies in the space include Aetna (AET), Anthem (ANTM), Centene (CNC), Health Net (HNT), Humana (HUM), UnitedHealth (UNH) and WellCare (WCG). 2. FOX NEWS: Former homicide detective Rod Wheeler has filed a lawsuit alleging the White House worked with Fox News (FOX; FOXA) and Republican donor Ed Butowsky to create a story regarding the murder of Democratic National Committee staffer Seth Rich in an attempt to distract from Russia investigations, CNN reports, citing the lawsuit. Wheeler, who was hired by Butowsky to look into Rich's death, claims Fox fabricated quotes attributed to him in an effort to support unproven theories that Rich provided Wikileaks with DNC emails and his murder was retribution for the leak. 3. OIL: According to a Bloomberg report on Wednesday, the White House is prepared to levy additional sanctions on Venezuela to counter repression by its President Nicolas Maduro, with restrictions on oil trade among the options being considered. Officials are said to be divided over the idea of restricting imports of crude from Venezuela, the publication said, adding that oil companies have warned that limits on Venezuelan oil imports could disadvantage Gulf and East Coast refiners designed to handle the country's crude and cause gasoline prices to spike. Publicly traded companies in the energy and refining space include Delek US (DK), HollyFrontier (HFC), Marathon Petroleum (MPC), Phillips 66 (PSX), Tesoro (TSO), Valero (VLO), Western Refining (WNR), BP (BP), Chevron (CVX), ConocoPhillips (COP), Exxon Mobil (XOM), Royal Dutch Shell (RDS.A) and Total (TOT). 4. TOYOTA, MAZDA PLANT PLANS: Toyota Motor (TM) and Mazda Motor (MZDAF) announced that they have signed an agreement to enter a business and capital alliance, as part of which the car companies will examine detailed plans with the goal to starting operations of a joint venture manufacturing plant in the U.S. in 2021. The factory will require a total investment of approximately $1.6B, and will create up to 4,000 jobs, the companies said. In response, President Trump tweeted that the plan represents "a great investment in American manufacturing!" 5. METLIFE WANTS "MORE": During its second quarter earnings call earlier this week, MetLife (MET) said elected officials "need to do more" on the fiscal policy front, "especially through tax reform" to spur faster economic growth. "Week in Review" is The Fly's weekly recap of its recurring series of "Trump Effect" exclusive stories.

CI

Cigna

$172.55

-3.5 (-1.99%)

MOH

Molina Healthcare

$59.80

-2.52 (-4.04%)

AET

Aetna

$156.79

-1.75 (-1.10%)

ANTM

Anthem

$190.48

-0.96 (-0.50%)

CNC

Centene

$82.38

-0.81 (-0.97%)

HNT

Health Net

$0.00

(0.00%)

HUM

Humana

$245.93

-2.91 (-1.17%)

UNH

UnitedHealth

$194.88

0.11 (0.06%)

WCG

WellCare

$173.21

-9.31 (-5.10%)

FOX

21st Century Fox

$28.06

-0.46 (-1.61%)

FOXA

21st Century Fox

$28.46

-0.36 (-1.25%)

DK

Delek US

$25.23

0.24 (0.96%)

HFC

HollyFrontier

$30.53

-0.03 (-0.10%)

MPC

Marathon Petroleum

$55.79

-0.1 (-0.18%)

PSX

Phillips 66

$85.60

-0.05 (-0.06%)

TSO

Tesoro

$0.00

(0.00%)

VLO

Valero

$68.53

0.03 (0.04%)

WNR

Western Refining

$0.00

(0.00%)

BP

BP

$36.33

0.19 (0.53%)

CVX

Chevron

$110.11

0.68 (0.62%)

COP

ConocoPhillips

$45.56

0.65 (1.45%)

XOM

Exxon Mobil

$80.21

-0.28 (-0.35%)

RDS.A

Royal Dutch Shell

$57.34

0.3 (0.53%)

TOT

Total

$51.92

0.47 (0.91%)

TM

Toyota

$113.64

0.91 (0.81%)

MZDAF

Mazda

$15.24

-1.15 (-7.02%)

MET

MetLife

$53.92

0.42 (0.79%)

  • 09

    Aug

  • 09

    Aug

  • 14

    Aug

  • 14

    Aug

  • 15

    Aug

  • 29

    Aug

  • 26

    Sep

  • 27

    Sep

CI Cigna
$172.55

-3.5 (-1.99%)

07/12/17
FBCO
07/12/17
INITIATION
Target $195
FBCO
Neutral
Anthem initiated with a Neutral at Credit Suisse
Credit Suisse analyst Scott Fidel started Anthem with a Neutral rating and $195 price target. The company has produced slower earnings growth over the past decade relative to Managed Care peers and its returns on capital are also "sub-par relative to comps," the analyst contends. He believes Anthem is "entering a new chapter" following the failed Cigna (CI) acquisition and "uncertain future" of the Affordable Care Act's exchanges and Medicaid expansion.
06/16/17
06/16/17
NO CHANGE

Leerink reiterates view that Cigna could bid for Humana
Leerink analyst Ana Gupte reiterated his views that Cigna (CI) could make a bid Humana (HUM) following Cigna's disclosure that 60% of its Medicare Advantage plans will be in 4-STAR rated plans. The announcement is most positive for Humana (HUM) which is the largest pure play Medicare Advantage name, but also paves the way for Cigna to potentially dievest its legacy HS Medicare Advantage book and bid for Humana.
06/23/17
JEFF
06/23/17
NO CHANGE
JEFF
Jefferies says healthcare rally 'appropriate' after 'toothless' AHCA rewrite
Jefferies analyst David Windley said the rally yesterday in healthcare stocks was appropriate given the "anemic" rewrite of the AHCA healthcare bill by Senate Republicans. The key changes are removal of "pay-for" taxes, a somewhat longer runway for Exchange cost-sharing reduction subsidies, and delayed Medicaid transition to per capita caps, he tells investors. Windley called Cigna (CI) "probably the safest MCO in this noise", adding that Humana (HUM) would benefit most from the proposed removal of the health insurer fee. Other publicly traded healthcare insurers include Aetna (AET), Anthem (ANTM), Centene (CNC), Health Net (HNT), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
06/23/17
LEER
06/23/17
NO CHANGE
LEER
Outperform
Draft version of Senate healthcare bill better than expected, says Leerink
Leerink analyst Ana Gupte said she views the draft version of the Senate healthcare bill as better than expected, stating that stabilization of the Exchanges and risk stabilization is a direct positive for health insurers and indirect positive for facility operators. The Senate bill maintains the House bill's plan to repeal all "ObamaCare" industry fees and taxes, which is a positive for Managed Care and Medical Technology players, Gupte adds. She keeps Outperform ratings on Anthem (ANTM), UnitedHealth (UNH), Cigna (CI), Humana (HUM), WellCare (WCG), Molina Healthcare (MOH) and acute care hospital operators HCA Holdings (HCA), Tenet (THC) and LifePoint (LPNT).
MOH Molina Healthcare
$59.80

-2.52 (-4.04%)

06/14/17
LEER
06/14/17
NO CHANGE
Target $80
LEER
Outperform
Molina Healthcare price target raised to $80 from $70 at Leerink
Leerink analyst Ana Gupte raised her price target for Molina Healthcare shares to $80 and remains "bullish" on the name after a call with CFO and interim CEO Joseph White. The analyst says White aligned with her view that the upcoming re-procurement of State Medicaid contracts "does not pose meaningful downside risk." Further, she learned the CEO search is making good progress with an "attractive slate" of senior executives with Managed Care experience. The analyst keeps an Outperform rating on Molina.
07/25/17
LEER
07/25/17
NO CHANGE
Target $80
LEER
Outperform
Leerink remains bullish on Molina Healthcare after job cut announcement
Leerink analyst Ana Gupte continues to have "strong conviction" on Molina Healthcare and reiterates an Outperform rating and a $80 price target after the company's announcement from its interim CEO and CFO Joseph White on the elimination of 1,400 jobs, or 10% of its corporate and health plan workforce. The analyst estimates this could expand margins by over 50 bps or offer 50% net margin expansion and get the company by the end of September to the low end of the stated target of 1.5%-2% net margins.
AET Aetna
$156.79

-1.75 (-1.10%)

06/28/17
SBSH
06/28/17
NO CHANGE
Target $205
SBSH
Buy
Anthem removed from Focus List at Citi
Citi analyst Ralph Giacobbe removed Anthem (ANTM) from his firm's Focus List but keeps a Buy rating on the shares with a $205 price target. The analyst believes some of the upside catalysts have played out. He also added Aetna (AET) to the Focus List.
06/28/17
06/28/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Altaba (AABA) initiated with an Overweight at JPMorgan. 2. Aetna (AET) and Humana (HUM) were initiated with a Buy at Citi. The firm also added Aetna to its Focus List. 3. CVS Health (CVS) and Walgreens Boots Alliance (WBA) were initiated with a Hold at Needham. 4. Oaktree Capital (OAK) initiated with a Hold at Jefferies. 5. General Motors (GM) resumed with an Overweight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/14/17
PIPR
07/14/17
NO CHANGE
Target $18
PIPR
Overweight
Piper views updated Aetna policy as disappointing for Natera
Piper Jaffray analyst William Quirk views Aetna's (AET) updated non-invasive prenatal testing medical policy, where it decided to continue covering the test only in high risk, as "disappointing." Upside for Natera (NTRA) in the second half of 2017 now falls on Medicaid and microdeletion reimbursement progress, and less so commercial payers flipping to cover average risk, Quick tells investors in a research note. He keeps an Overweight rating on Natera shares with an $18 price target.
07/13/17
FBCO
07/13/17
NO CHANGE
Target $165
FBCO
Outperform
Aetna price target raised to $165 from $160 at Credit Suisse
Credit Suisse analyst Scott Fidel raised his price target for Aetna to $165 from $160 ahead of Q2 results. He reiterates an Outperform rating on the shares.
ANTM Anthem
$190.48

-0.96 (-0.50%)

CNC Centene
$82.38

-0.81 (-0.97%)

07/26/17
PIPR
07/26/17
NO CHANGE
Target $105
PIPR
Overweight
Piper says double down on Centene, ups target to $105
Piper Jaffray analyst Sarah James attributes yesterday's post-earnings pullback in shares of Centene to the macro backdrop and the company's spending bump that she believes fuels the bear concern that constant spending for growth pressures margins. The analyst "strongly" disagrees and believe this is when investors should double down on Centene shares. The company will see the greatest multiple expansion in the group and has the highest potential for earnings upside, James tells investors in a research note. She raised her price target for the shares to $105 from $85 and keeps an Overweight rating on the name.
06/06/17
MSCO
06/06/17
INITIATION
Target $86
MSCO
Overweight
Centene initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst Zack Sopcak initiated Centene with an Overweight and a $86 price target. The analyst thinks the HealthNet acquisition provides diversification and entry planned expansion in Medicare Advantage could offset potential headwinds.
07/11/17
BERN
07/11/17
NO CHANGE
BERN
Centene price target raised to $100 from $85 at Bernstein
Bernstein analyst Lance Wilkes raised his price target on Centene based on his belief that the managed Medicaid market will grow over the long-term, particularly in long-term care. He keeps an Outperform rating on the stock.
HNT Health Net
$0.00

(0.00%)

11/09/16
BERN
11/09/16
NO CHANGE
BERN
Health insurers to see multiple catalysts from Trump presidency, says Bernstein
Bernstein analyst Lance Wilkes says that "repealing and replacing Obamacare will be Trump's primary focus." The analyst expects health insurers to benefit from from the repeal of ACA taxes and the elimination of requirements to spend a certain percentage of revenue on medical costs. Wilkes expects Anthem (ANTM) and Blue Cross/Blue Shield providers to benefit from the elimination of public exchanges and broad coverage requirements. Other health insurers include Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
HUM Humana
$245.93

-2.91 (-1.17%)

08/03/17
PIPR
08/03/17
NO CHANGE
Target $280
PIPR
Overweight
Humana price target raised to $280 from $246 at Piper Jaffray
Piper Jaffray analyst Sarah James raised her price target for Humana to $280 saying the company reported a "strong" beat and raise quarter driven by "strong" Medicare Advantage performance and improved cost control. The analyst sees upside to the current share price and keeps an Overweight rating on Humana.
08/03/17
OPCO
08/03/17
NO CHANGE
Target $255
OPCO
Outperform
Humana price target raised to $255 from $236 at Oppenheimer
Oppenheimer analyst Michael Wiederhorn raised his price target for Humana to $255 from $236 following "strong results" that were driven by outperformance in Medicare Advantage, and after the company raised 2017 EPS guidance. The analyst reiterates an Outperform rating on the shares.
08/03/17
FBCO
08/03/17
NO CHANGE
Target $260
FBCO
Outperform
Humana price target raised to $260 from $250 at Credit Suisse
Credit Suisse analyst Scott Fidel raised his price target for Humana to $260 from $250 following quarterly results. The analyst reiterates an Outperform rating on the shares.
07/13/17
FBCO
07/13/17
NO CHANGE
Target $250
FBCO
Outperform
Humana price target raised to $250 from $245 at Credit Suisse
Credit Suisse analyst Scott Fidel raised his price target for Humana to $250 from $245 ahead of Q2 results. He reiterates an Outperform rating on the shares.
UNH UnitedHealth
$194.88

0.11 (0.06%)

06/27/17
KEYB
06/27/17
DOWNGRADE
KEYB
Sector Weight
LabCorp downgraded on potential acquisition at KeyBanc
As noted earlier, KeyBanc downgraded LabCorp to Sector Weight from Overweight. Analyst Donald Hooker downgraded the stock based on his belief that the company implied that it may make an "expensive" deal to acquire a contract research organization. The analyst adds that the upcoming renewal of the company's contract with UnitedHealth (UNH) in 2H18 creates uncertainty.He expects to hear news about the deal "in coming months."
07/19/17
UBSW
07/19/17
NO CHANGE
Target $213
UBSW
Buy
UnitedHealth price target raised to $213 from $194 at UBS
UBS analyst A.J. Rice raised his price target on UnitedHealth to $213 from $194 following Q2 earnings. The analyst cited the company's positive outlook to gain market share in both group and individual Medicare Advantage markets along with continued growth assumptions for Optum Rx. Rice reiterated his Buy rating on UnitedHealth shares.
07/28/17
WELS
07/28/17
NO CHANGE
Target $9
WELS
Underperform
Insurers are dropping Valeant's top products, says Wells Fargo
United Healthcare's (UNH) formulary is no longer covering Valeant Pharmaceuticals' (VRX) number three branded drug Solodyn and will also now exclude Retin-A brand, its number four branded drug, Wells Fargo analyst David Maris tells investors in a research note. The analyst estimates the two drugs represented approximately $214M of Valeant's sales in 2016. Maris also points out that Glumetza, Valeant's number eight branded drug, and Relistor were removed in July from CVS/Caremark's (CVS) formulary. These two drugs had approximately $119M in 2016 revenues. Maris notes his counterpart Peter Costa estimates that United Healthcare covers approximately 17% of the U.S. and CVS covers approximately 33%. Express Scripts (ESRX) is releasing its 2018 national formulary next week, Costa adds. Maris keeps an Underperform rating on shares of Valeant with a $9 price target. The stock in premarket trading is down 33c, or 2%, to $16.80.
07/13/17
FBCO
07/13/17
NO CHANGE
Target $200
FBCO
Outperform
UnitedHealth price target raised to $200 from $195 at Credit Suisse
Credit Suisse analyst Scott Fidel raised his price target for UnitedHealth to $200 from $195 ahead of Q2 results. He reiterates an Outperform rating on the shares.
WCG WellCare
$173.21

-9.31 (-5.10%)

06/06/17
MSCO
06/06/17
INITIATION
Target $183
MSCO
Equal Weight
WellCare initiated with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Zack Sopcak initiated WellCare with an Equal Weight rating and $183 price target, citing its current valuation.
07/13/17
FBCO
07/13/17
NO CHANGE
Target $163
FBCO
Neutral
WellCare price target raised to $163 from $155 at Credit Suisse
Credit Suisse analyst Scott Fidel raised his price target for WellCare to $163 from $155 ahead of Q2 results. He reiterates a Neutral rating on the shares.
FOX 21st Century Fox
$28.06

-0.46 (-1.61%)

08/01/17
FBCO
08/01/17
NO CHANGE
Target $37
FBCO
Outperform
21st Century Fox, Sky deal to take longer to clear, says Credit Suisse
Credit Suisse analyst Omar Sheikh continues to believe the Sky (SKYAY) transaction will eventually receive full regulatory approval, but highlights there is an elevated risk to the deal if it is referred to the CMA, and at best an extended period before it gets cleared. Meanwhile, he believes the 2018 21st Century Fox (FOXA) organic equity story looks compelling, and reiterates an Outperform rating and $37 price target on the shares.
07/25/17
OTRG
07/25/17
DOWNGRADE
OTRG
Mixed
21st Century Fox downgraded to Mixed from Positive at OTR Global
OTR Global downgraded 21st Century Fox to Mixed from Positive
04/26/17
FBCO
04/26/17
NO CHANGE
Target $37
FBCO
Outperform
Hulu stake could be for sale this year, says Credit Suisse
Credit Suisse analyst Omar Sheikh notes that Comcast (CMCSA; CMCSK) will be free to sell its 30% stake in Hulu from the end of 2017. The analyst believes there is a $100B domestic revenue opportunity for targeted TV advertising long-term, which vertically integrated networks/distributors will be in a strong position to exploit. Therefore, Sheikh argues that it would make sense for 21st Century Fox (FOX; FOXA) to acquire Comcast's stake in Hulu, if it becomes available, subject to valuation and appropriate programming supply agreements. He reiterates an Outperform rating and $37 price target on 21st Century Fox's shares.
04/04/17
PIVT
04/04/17
NO CHANGE
Target $36
PIVT
Buy
Boycotts of O'Reilly Factor likely manageable for now, says Pivotal Research
Pivotal Research analyst Brian Wieser said advertiser boycotts of O'Reilly Factor are likely manageable and only slightly negative at this time, but added that a more significant concern is the potential for this to impact Ofcom's "fit and proper" test related to Fox's (FOXA) proposed takeover of Sky (SKYAY). Wieser, who views the Sky acquisition as a favorable strategic combination, would sees the U.K. regulator not allowing the transaction to proceed as a negative. However, he keeps a Buy rating and $36 price target on Fox shares.
FOXA 21st Century Fox
$28.46

-0.36 (-1.25%)

07/14/17
WELS
07/14/17
NO CHANGE
WELS
Nexstar Fox deal positive, says Wells Fargo
Wells Fargo says the market is failing to fully appreciate Nexstar's (NXST) deal with 21st Century Fox (FOXA). The analyst says that the OTT master agreement within the deal was positive and removes an overhang on Nexstar. Wells says that the company's management "is doing everything right," and it recommends buying the stock now.
06/26/17
SBSH
06/26/17
NO CHANGE
SBSH
Buy
21st Century Fox valuation discount to peers is 'odd,' says Citi
Citi analyst Jason Bazinet calls 21st Century Fox's (FOXA) valuation discount to peers like Scripps Networks (SNI) and Discovery (DISCA) "odd." Fox is both structurally better positioned than peers and has less advertising exposure, Bazinet tells investors in a research note. He believes 2018 consensus estimates for the company are "fairly achievable" and keeps a Buy rating on the shares.
DK Delek US
$25.23

0.24 (0.96%)

07/14/17
SBSH
07/14/17
DOWNGRADE
Target $29
SBSH
Neutral
Delek US downgraded to Neutral from Buy at Citi
Citi analyst Faisel Khan downgraded Delek US Holdings to Neutral with an unchanged price target of $29.
07/11/17
JPMS
07/11/17
INITIATION
Target $28
JPMS
Neutral
Delek US reinstated with a Neutral at JPMorgan
JPMorgan analyst Phil Gresh reinstated Delek US Holdings with a Neutral rating and $28 price target.
07/25/17
WOLF
07/25/17
UPGRADE
WOLF
Outperform
Delek US upgraded to Outperform from Peer Perform at Wolfe (pre-open)
07/05/17
07/05/17
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Pandora (P) resumed with an Overweight at Morgan Stanley. 2. Two Harbors (TWO) reinstated with an Outperform at Credit Suisse. 3. Alcentra Capital (ABDC) initiated with a Buy at DA Davidson. 4. Alon USA Partners (ALDW) reinstated with an Equal Weight at Barclays. 5. Delek US (DK) and Delek Logistics (DKL) were reinstated with an Equal Weight at Barclays. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
HFC HollyFrontier
$30.53

-0.03 (-0.10%)

08/02/17
SCOT
08/02/17
UPGRADE
SCOT
Outperform
HollyFrontier upgraded to Outperform from Sector Perform at Scotiabank
05/16/17
GSCO
05/16/17
DOWNGRADE
Target $73
GSCO
Neutral
Valero downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Neil Mehta downgraded Valero (VLO) to Neutral citing a more balanced risk/reward following the stock's outperformance. Further, the analyst thinks the upcoming OPEC meeting could drive further compression of the light-heavy differential. He lowered his 6-month target for the shares to $73 from $74. Mehta this morning also upgraded Delek US (DK) to Buy, kept a Buy rating on Marathon Petroleum (MRC) and a Sell rating on HollyFrontier (HFC).
05/04/17
FBCO
05/04/17
DOWNGRADE
FBCO
Neutral
HollyFrontier downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Edward Westlake downgraded Holly Frontier to Neutral from Outperform and lowered its price target to $30 from $33 saying refining margins and crude spreads are not sufficient enough to re-rate shares absent corporate tax reform.
03/24/17
FBCO
03/24/17
NO CHANGE
Target $32
FBCO
Outperform
HollyFrontier price target lowered to $32 from $36 at Credit Suisse
Credit Suisse analyst Edward Westlake lowered his price target for HollyFrontier to $32 from $36 on valuation. The analyst notes that after rallying into the end of the year, HollyFrontier has sold off on margin worries and high product inventories, but should bounce back so long as operations stay on target and the margin environment improves seasonally. He reiterates an Outperform rating on the shares.
MPC Marathon Petroleum
$55.79

-0.1 (-0.18%)

05/25/17
PIPR
05/25/17
UPGRADE
Target $62
PIPR
Overweight
Marathon Petroleum assumed with an Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Guy Baber upgraded Marathon Petroleum to Overweight after assuming coverage of the name. The analyst raised his price target for the shares to $62 from $48. The analyst notes Tesoro (TSO) remains his top pick in the space.
05/25/17
05/25/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Chipotle (CMG) upgraded to Buy from Hold at Argus with analyst John Staszak saying he expects Chipotle to post above-peer-average growth over the next several quarters due to its new marketing initiatives, differentiated menu and unit expansion plans. Further, Staszak sees fast-casual restaurants like Chipotle growing faster than the overall restaurant industry. He points out that Chipotle posted a strong recovery in both comp sales and earnings in the first quarter. 2. Alliance Data (ADS) upgraded to Neutral from Sell at Compass Point. 3. PVH Corp. (PVH) upgraded to Overweight from Neutral at JPMorgan with analyst Matthew Boss citing the company's first quarter results. The beat and raise story in retail is a rarity, Boss tells investors in a research note. He sees increased visibility to a "sustainable double-digit bottom-line profile" over the longer term. 4. Marathon Petroleum (MPC) and Phillips 66 (PSX) were assumed with an Overweight from Neutral at Piper Jaffray. 5. Alexion (ALXN) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Matthew Harrison saying he believes investors are overlooking ALXN1210 upside potential, are too negative on Solris and believes new Chief Executive Officer Ludwig Hantson is making progress on refocusing efforts and right sizing the company. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/20/17
JEFF
07/20/17
NO CHANGE
Target $65
JEFF
Buy
Marathon Petroleum removed as Franchise Pick at Jefferies
Jefferies analyst Corey Goldman removed Marathon Petroleum from his firm's Franchise Pick list saying he sees "only modest upside" if a Speedway separation were to occur. As such, he does not expect Marathon to execute a tax-free separation of Speedway. The analyst keeps a Buy rating on the shares with a $65 price target.
PSX Phillips 66
$85.60

-0.05 (-0.06%)

03/24/17
FBCO
03/24/17
NO CHANGE
Target $83
FBCO
Neutral
Phillips 66 price target lowered to $83 from $90 at Credit Suisse
Credit Suisse analyst Edward Westlake lowered his price target for Phillips 66 to $83 from $90 on valuation. The analyst notes that Phillips 66 has been one of the more fully valued refiners for quite some time, but is getting closer to the time when the cash flow power of the company will expand to support its enterprise value. He reiterates a Neutral rating on the shares.
09/30/16
09/30/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) upgraded on potential NXP Semiconductors acquisition at Mizuho with the firm's analyst saying he believes a Qualcomm acquisition of NXP Semiconductors (NXPI) makes significant strategic and financial sense. 2. Skechers (SKX) upgraded to Positive from Neutral at Susquehanna. 3. Sprouts Farmers Markets (SFM) upgraded to Buy from Hold at Jefferies with analyst Christopher Mandeville saying the risk/reward is now favorable following the recent pullback in the shares. 4. Phillips 66 (PSX) upgraded to Neutral from Sell at Goldman with analyst Neil Mehta citing higher multiple assumptions for midstream and chemicals segments, reduced capex spending and higher free cash flow estimates, and more achievable consensus expectations. 5. NetApp (NTAP) upgraded to Buy from Sell at Summit Redstone with analyst Srini Nandury citing optimism that the company can grow its product revenue from current levels driven by AFA sales and increasing adoption of clustered ONTAP. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/25/17
PIPR
05/25/17
UPGRADE
Target $88
PIPR
Overweight
Phillips 66 assumed with an Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Guy Baber upgraded Phillips 66 (PSX) to Overweight after assuming coverage of the name. The analyst keeps an $88 price target for the shares. He notes Tesoro (TSO) remains his top pick in the space.
TSO Tesoro
$0.00

(0.00%)

06/13/17
06/13/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Clovis (CLVS) initiated with an Outperform at Leerink. 2. Arconic (ARNC) resumed with an Equal Weight at Morgan Stanley. 3. Tesoro (TSO) reinstated with a Conviction Buy at Goldman Sachs. 4. Golden Ocean (GOGL) initiated with a Buy at Seaport Global. 5. International Seaways (INSW) initiated with an Overweight at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/27/17
GSCO
06/27/17
NO CHANGE
Target $121
GSCO
Conviction Buy
West Coast refining outlook not priced into Tesoro shares, say Goldman Sachs
Goldman analyst Neil Mehta expects West Coast inventories to remain relative balanced through 2017 despite the re-start of the Torrance refinery expected later this month due to strong export trends and demand levels. Mehta views Tesoro's risk/reward as attractive at current levels given the underappreciated value in its non-refining business segments, the completion of the Western Refining acquisition which will expand a Permian logistics network, provide access to Phoenix retail, and improves margins at the Mid-Continent refining segment, and capital allocation opportunities. The analyst reiterates his Conviction Buy and $121 price target on Tesoro shares.
06/05/17
DBAB
06/05/17
UPGRADE
Target $106
DBAB
Buy
Tesoro upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Ryan Todd upgraded Tesoro to Buy with an unchanged price target of $106.
06/13/17
GSCO
06/13/17
INITIATION
Target $121
GSCO
Conviction Buy
Tesoro reinstated with a Conviction Buy at Goldman Sachs
Goldman analyst Neil Mehta reinstated Tesoro with a Conviction Buy and a $121 price target saying he sees upside from the Western Refining acquisition and sees attractive value in the midstream and marketing businesses.
VLO Valero
$68.53

0.03 (0.04%)

05/30/17
05/30/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Ambarella (AMBA) downgraded to Sector Weight from Overweight at Pacific Crest with analyst Brad Erickson citing concern the company's largest customer DJI may have dual-sourced. After speaking with DJI customer service, Erickson believes Ambarella may not be the video processing provider for Spark, the $499 drone launched last week by DJI. 2. Buffalo Wild Wings (BWLD) downgraded to Underperform from Neutral at Wedbush with analyst Nick Setyan saying the upcoming proxy vote is irrelevant as neither management's strategy nor Marcato Capital's plan offer a viable solution to the company's ongoing deterioration in fundamentals. 3. Valero (VLO) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Benny Wong citing refining headwinds and high exposure to RIN prices. 4. AutoZone (AZO) and O'Reilly Automotive (ORLY) were downgraded to Neutral from Outperform at Wedbush. 5. Whiting Petroleum (WLL) was downgraded to Sell from Neutral at Goldman Sachs, while Cimarex Energy (XEC) and Hess Corp. (HES) were downgraded to Neutral from Buy. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/30/17
STPT
06/30/17
INITIATION
Target $84
STPT
Reduce
Valero initiated with an Accumulate at Standpoint Research
Standpoint Research analyst Ronnie Moas started Valero with an Accumulate rating and $84 price target.
06/02/17
LEHM
06/02/17
INITIATION
Target $118
LEHM
Overweight
Tesoro reinstated with an Overweight at Barclays
Barclays analyst Paul Cheng reinstated coverage of Tesoro (TSO) with an Overweight rating and $118 price target. Tesoro replaces Valero (VLO) as his Top Pick in the Refiners sector following its acquisition of Western Refining.
06/22/17
JEFF
06/22/17
UPGRADE
Target $80
JEFF
Buy
Valero upgraded to Buy from Hold at Jefferies
Jefferies analyst Christopher Sighinolfi upgraded Valero to Buy from Hold, stating that he expects U.S. crude exports to climb "meaningfully" through the end of the decade. As the largest PADD 3 refiner, he sees Valero's Gulf Coast margin capture improving through 2018, he tells investors. Sighinolfi raised his price target on Valero shares to $80 from $65.
WNR Western Refining
$0.00

(0.00%)

03/24/17
FBCO
03/24/17
DOWNGRADE
FBCO
Neutral
Western Refining downgraded to Neutral from Outperform at Credit Suisse
04/06/17
JPMS
04/06/17
NO CHANGE
Target $97
JPMS
Overweight
Tesoro pullback a buying opportunity, says JPMorgan
JPMorgan analyst Phil Gresh recommends using the pullback in Tesoro (TSO) shares to below $80 as a buying opportunity. The analyst continues to believe that closing the Western Refining (WNR) deal will be a "key fundamental and technical catalyst" for the stock. He lowered his price target for Tesoro shares to $97 from $98 and keeps an Overweight rating on the name.
05/30/17
MSCO
05/30/17
UPGRADE
Target $110
MSCO
Overweight
Tesoro upgraded to Overweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst Benny Wong upgraded Tesoro (TSO) to Overweight and raised its price target to $110 from $100. The analyst said Tesoro's the acquisition of Western Refining (WNR) diversifies growth, expands its integrated strategy, and a potential MLP restructuring would unlock value. Further, the analyst sees upside from a potential pickup in Permian margins, strong West Coast cracks, and synergies.
03/24/17
03/24/17
DOWNGRADE
Target $40

Neutral
Western Refining downgraded to Neutral at Credit Suisse
As previously reported, Credit Suisse analyst Edward Westlake downgraded Western Refining (WNR) to Neutral from Outperform as acquisition nears. The analyst notes that the combination of Western Refining/Tesoro (TSO) creates synergistic overlap in the South West product markets and around St. Paul Park/Mandan plus opportunities to offer full service logistics to customers in the Permian and Bakken. The analyst lowered his price target on Western Refining's shares to $40 from $48 to reflect the acquisition offer exchange rate.
BP BP
$36.33

0.19 (0.53%)

07/26/17
SOCG
07/26/17
DOWNGRADE
SOCG
Hold
BP downgraded to Hold from Buy at Societe Generale
Societe Generale analyst Irene Himona downgraded BP to Hold due to higher relative valuation, lower ROACE, and lower organic free cash flow yield versus the sector.
07/11/17
BERN
07/11/17
NO CHANGE
BERN
Oil price forecast cut at Bernstein
Bernstein analysts lowered their 2017 and 2018 oil price forecasts to $50 per barrel for both years. As reasons for the drop, the firm cited higher U.s. shale efficiency, their belief that elevated production levels will last longer than previously expected, and their belief that OPEC cuts will be insufficient to counter increased production by Libya, Iran and Nigeria. Publicly traded companies in the oil space include BP (BP), Chevron (CVX), ConocoPhillips (COP), Exxon Mobil (XOM), Royal Dutch Shell (RDS.A) and Total (TOT).
05/02/17
BERN
05/02/17
NO CHANGE
BERN
BP shares should be bought ahead of 2H17, says Bernstein
Bernstein analyst Oswald Clint says that BP's Q1 results indicate that the company's upstream and downstream businesses are "beginning to rev." The analyst expects the company's volume, margin and cash flow to all reach positive turning points in 2H17, and he recommends that investors buy the stock.
06/21/17
MACQ
06/21/17
DOWNGRADE
MACQ
Underperform
BP downgraded to Underperform from Neutral at Macquarie
Macquarie analyst Iain Reid downgraded BP to Underperform following a reduction in the firm's oil price estimates saying the majors will slip back into deficits and have further, painful cost reductions. The firm lowered its its second half 2017 Brent forecast to $54.15 from $58.76 and WTI forecast to $52.15 from $56.75, 2018 Brent forecast to $49.33 from $55.75 and WTI forecast to $46.08 from $52.50, and 2019 Brent forecast to $65 from $70 and WTI forecast to $60 from $65.
CVX Chevron
$110.11

0.68 (0.62%)

06/21/17
06/21/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Intel (INTC) downgraded to Neutral from Buy at BofA/Merrill with analyst Vivek Arya saying he fears increased competition from AMD (AMD) in servers and Nvidia (NVDA) share gains in AI and accelerators could limit Intel's average selling price expansion, which he notes has been a key source of its growth. Arya cut his price target on Intel shares to $38 from $42. 2. Target (TGT) downgraded to Neutral from Buy at Citi. 3. Chevron (CVX) downgraded to Neutral from Outperform at Macquarie. 4. Schlumberger (SLB) downgraded to Equal Weight from Overweight at Barclays with analyst J. David Anderson saying that based on strip prices and the firm's oil price forecast he expects 2018 North America E&P spending to be up about 10-15%. 5. Embraer (ERJ) downgraded to Market Perform from Outperform at Cowen with analyst Cai Von Rumohrciting the increasing likelihood of a transitional earnings dip as E2 enters production with another year of cash outflow in 2018. Although 2019 looks notionally better, the stock faces a tough earnings revision set-up in the second half of this year. Von Rumohr lowered his price target to $24 from $27 on Embraer shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/17/17
WOLF
07/17/17
DOWNGRADE
WOLF
Peer Perform
Chevron downgraded to Peer Perform from Outperform at Wolfe Research
07/06/17
RBCM
07/06/17
DOWNGRADE
RBCM
Underperform
Chevron downgraded to Underperform from Sector Perform at RBC Capital
COP ConocoPhillips
$45.56

0.65 (1.45%)

07/17/17
WOLF
07/17/17
DOWNGRADE
WOLF
Peer Perform
ConocoPhillips downgraded to Peer Perform from Outperform at Wolfe Research
07/28/17
BOFA
07/28/17
UPGRADE
Target $58
BOFA
Buy
ConocoPhillips upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Doug Leggate upgraded ConocoPhillips to Buy and raised its price target to $58 from $51 saying portfolio repositioning has lowered capital intensity and will drive free cash flow improvement. The company lowered its breakeven to $45/bbl from $50/bbl in November of 2016 providing capacity for renewed growth capital or buybacks.
07/28/17
07/28/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. ConocoPhillips (COP) upgraded to Buy from Neutral at BofA/Merrill with analyst Doug Leggate saying portfolio repositioning has lowered capital intensity and will drive free cash flow improvement. 2. Boeing (BA) upgraded to Neutral from Underperform at Buckingham. 3. J.M. Smucker (SJM) upgraded to Buy from Hold at Jefferies with analyst Akshay Jagdale saying the recent share weakness is overdone. 4. Domino's Pizza (DPZ) upgraded to Buy from Neutral at Longbow. 5. Spirit Airlines (SAVE) upgraded to Buy from Neutral at Citi with analyst Kevin Crissey saying the risks are more than priced in at current share levels. He cut his price target for the shares to $52 from $65. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
XOM Exxon Mobil
$80.21

-0.28 (-0.35%)

07/17/17
WOLF
07/17/17
DOWNGRADE
WOLF
Underperform
Exxon Mobil downgraded to Underperform from Peer Perform at Wolfe Research
07/11/17
07/11/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. KeyCorp (KEY) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Brian Klock saying he sees valuation expansion as the market further appreciates the company's leading return on assets and stable earnings. 2. Exxon Mobil (XOM) and Imperial Oil (IMO) were upgraded to Overweight from Equal Weight at Barclays. 3. Westar Energy (WR) was upgraded to Outperform from In Line at Evercore ISI and to Overweight from Neutral at JPMorgan. 4. STMicroelectronics (STM) upgraded to Overweight from Neutral at JPMorgan with analyst Sandeep Deshpande citing the stock's underperformance over the past three months. 5. J.M. Smucker (SJM) upgraded to Long-Term Buy on valuation at Hilliard Lyons with analyst Jeffrey Thomison citing the recent decline in shares and maintained a $140 price target. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/11/17
LEHM
07/11/17
UPGRADE
Target $94
LEHM
Overweight
Exxon Mobil upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Paul Cheng upgraded Exxon Mobil to Overweight citing the recent underperformance of the shares as well as the company's "leading near-term position" in the current commodity price environment. The analyst keeps a $94 price target for the shares.
RDS.A Royal Dutch Shell
$57.34

0.3 (0.53%)

07/19/17
BERN
07/19/17
NO CHANGE
BERN
Worries about European LNG overdone, says Bernstein
Bernstein analyst Oswald Clint says that worries about the European LNG sector are overdone given strong demand and relatively low imports from the U.S. The analyst says that "Statoil (STO) and Shell (RDS.A) are the most exposed to European gas and LNG respectively." He keeps Outperform rating son both stocks.
05/26/17
EXAN
05/26/17
UPGRADE
EXAN
Outperform
Royal Dutch Shell upgraded to Outperform from Neutral at Exane BNP Paribas
Exane BNP Paribas analyst Theepan Jothilingam upgraded Royal Dutch Shell to Outperform from Neutral.
06/21/17
MACQ
06/21/17
DOWNGRADE
MACQ
Neutral
Royal Dutch Shell downgraded to Neutral from Outperform at Macquarie
Macquarie analyst Iain Reid downgraded Royal Dutch Shell to Neutral following a reduction in the firm's oil price estimates saying the majors will likely slip back into deficits and have further, painful cost reductions. The firm lowered its its second half 2017 Brent forecast to $54.15 from $58.76 and WTI forecast to $52.15 from $56.75, 2018 Brent forecast to $49.33 from $55.75 and WTI forecast to $46.08 from $52.50, and 2019 Brent forecast to $65 from $70 and WTI forecast to $60 from $65.
TOT Total
$51.92

0.47 (0.91%)

07/21/17
07/21/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Capital One (COF) upgraded to Perform from Underperform at Oppenheimer with analyst Ben Chittenden saying the second quarter results point to signs of credit stabilization. 2. Juniper (JNPR) upgraded to Outperform from Market Perform at Raymond James with analyst Simon Leopold citing favorable risk/reward and an underappreciated "pivot" in the business. 3. CalAtlantic (CAA) upgraded to Outperform from Market Perform at JMP Securities with analyst Peter Martin saying he is increasingly optimistic that the stock can rise in 2018. 4. Total (TOT) upgraded to Buy from Hold at Canaccord. 5. SK Telecom (SKM) upgraded to Buy from Neutral at Goldman Sachs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/21/17
ADAM
07/21/17
UPGRADE
ADAM
Buy
Total upgraded to Buy from Hold at Canaccord
05/17/17
HOWW
05/17/17
DOWNGRADE
HOWW
Sector Perform
Total downgraded to Sector Perform from Outperform at Scotia Howard Weil
TM Toyota
$113.64

0.91 (0.81%)

06/28/17
DAIW
06/28/17
DOWNGRADE
DAIW
Neutral
Toyota downgraded to Neutral from Outperform at Daiwa
07/10/17
NEED
07/10/17
NO CHANGE
Target $200
NEED
Buy
Nvidia price target raised to $200 from $130 at Needham
Needham analyst Rajvindra Gill raised his price target for Nvidia (NVDA) to $200 on higher conviction that the company's agreement with Toyota (TM) will generate "meaningful" revenue over the next 24 months. The analyst believes the deal could generate up to $1.7B of incremental revenue. Meetings with Toyota confirm the automaker has aggressive plans to deploy Level 2 Advanced systems, which will be on Nvidia's Drive PX Xavier platform, in mass market in the U.S. and Japan over the next two-and-a-half years, Gill tells investors in a research note. He keeps a Buy rating on Nvidia. Jefferies this morning raised its price target on Nvidia to $180 from $140. The shares in premarket trading are up $2.23 to $149.00.
07/11/17
BOFA
07/11/17
DOWNGRADE
BOFA
Underperform
Toyota downgraded to Underperform from Neutral at BofA/Merrill
07/11/17
07/11/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Snap (SNAP) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Brian Nowak saying he now sees its advertising revenue growth being materially slower than he previously expected given the company's struggles to innovate and improve its ad product paired with the rising competition it faces from Facebook's (FB) Instagram. 2. Lennar (LEN), PulteGroup (PHM) downgraded to Equal Weight from Overweight at Barclays, and TRI Pointe (TPH) were downgraded to Equal Weight from Overweight at Barclays, while Toll Brothers (TOL) was downgraded to Underweight from Equal Weight. 3. Gildan Activewear (GIL) downgraded to Sector Perform from Outperform at RBC Capital with the firm's analyst citing year-to-date share strength and lack of meaningful upside to estimates. 4. PetMed Express (PETS) downgraded to Hold from Buy at Craig-Hallum with analyst Kevin Ellich saying risk/reward is balanced at current levels as the shares are up over 100% in the last 3 months. 5. Toyota (TM) downgraded to Underperform from Neutral at BofA/Merrill. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
MZDAF Mazda
$15.24

-1.15 (-7.02%)

MET MetLife
$53.92

0.42 (0.79%)

05/25/17
05/25/17
UPGRADE
Target $58

Outperform
MetLife upgraded to Outperform from Market Perform at FBR Capital
FBR Capital analyst Randy Binner upgraded MetLife to Outperform and raised his price target for the shares to $58 from $54. The analyst believes the Brighthouse spin, which he sees as progressing, sets up an attractive total return story.
07/24/17
JPMS
07/24/17
INITIATION
Target $78
JPMS
Neutral
Brighthouse Financial initiated with a Neutral at JPMorgan
JPMorgan analyst Jimmy Bhullar started MetLife (MET) spinoff Brighthouse Financial (BHF) with a Neutral rating and $78 price target. The analyst views the valuation as attractive but has a cautious outlook for business trends.
03/06/17
03/06/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. MetLife (MET) downgraded to Neutral from Buy at BofA/Merrill with analyst Seth Weiss saying shares are now trading above the level of the disappointing fourth quarter earnings report and prefers Prudential (PRU) given it benefits more from improving interest rates and easing regulations. 2. Procter & Gamble (PG) downgraded to Neutral from Buy at B. Riley with analyst Linda Bolton Weiser saying that while the stock is up 11% from the December low, the company's fundamentals have weakened. The analyst cut her price target for the shares to $91 from $106. 3. GoPro (GPRO) downgraded to Sell from Neutral at Goldman with analyst Simona Jankowski saying the company faces "significant challenges" amid camera market saturation, product rollout issues in the holiday season, and a disappointing entry into the drone market. The analyst sees risk to consensus estimates and views the stock as overvalued. 4. Hawaiian Electric (HE) downgraded to Underperform from In Line at Evercore ISI with analyst Greg Gordon saying he believes the risk/return for shares is skewed to the downside and estimates a "significantly lower total return" compared to other utilities he covers. He maintains a $31 price target on Hawaiian Electric shares. 5. Akorn (AKRX) downgraded to Hold from Buy at Deutsche Bank with analyst Gregg Gilbert saying the risk/reward is more balanced following the recent rally in the shares. Upside from current levels will have more to do with the "hard-to-call dynamics of new product approvals vs. base business erosion," Gilbert tells investors in a research note. He cut his price target for the shares to $24 from $28. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/06/17
03/06/17
DOWNGRADE
Target $59

Neutral
MetLife downgraded to Neutral at BofA/Merrill
As previously reported, BofA/Merrill downgraded MetLife (MET) to Neutral from Buy and maintained its $59 price target. Analyst Seth Weiss said shares are now trading above the level of the disappointing Q4 earnings report and prefers Prudential (PRU) given it benefits more from improving interest rates and easing regulations.

TODAY'S FREE FLY STORIES

KORS

Michael Kors

$68.63

0.25 (0.37%)

, LULU

Lululemon

$106.18

-0.19 (-0.18%)

11:07
05/26/18
05/26
11:07
05/26/18
11:07
Periodicals
Dollar Tree looks interesting, Barron's says »

Next week, another 20…

KORS

Michael Kors

$68.63

0.25 (0.37%)

LULU

Lululemon

$106.18

-0.19 (-0.18%)

GME

GameStop

$12.64

-0.1 (-0.78%)

DLTR

Dollar Tree

$95.23

0.59 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 31

    May

  • 31

    May

  • 12

    Jun

  • 14

    Jun

  • 26

    Jun

KHC

Kraft Heinz

$57.78

0.72 (1.26%)

, QCOM

Qualcomm

$59.95

0.85 (1.44%)

10:58
05/26/18
05/26
10:58
05/26/18
10:58
Periodicals
Kraft Heinz, J&J among safe, 'solid' dividend stocks, Barron's says »

Kraft Heinz (KHC),…

KHC

Kraft Heinz

$57.78

0.72 (1.26%)

QCOM

Qualcomm

$59.95

0.85 (1.44%)

MRK

Merck

$59.08

-0.03 (-0.05%)

TGT

Target

$71.22

0.28 (0.39%)

OMC

Omnicom

$71.98

-0.1 (-0.14%)

CCL

Carnival

$64.27

0.12 (0.19%)

JNJ

Johnson & Johnson

$121.40

0.06 (0.05%)

MMM

3M

$198.98

-0.38 (-0.19%)

LLY

Eli Lilly

$82.75

0.05 (0.06%)

VLO

Valero

$118.81

-3.06 (-2.51%)

EMR

Emerson

$72.50

-0.77 (-1.05%)

WBA

Walgreens Boots Alliance

$63.52

0.09 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 30

    May

  • 30

    May

  • 02

    Jun

  • 04

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 07

    Jun

  • 12

    Jun

  • 19

    Jun

  • 10

    Sep

  • 23

    Oct

MU

Micron

$61.33

-0.15 (-0.24%)

10:48
05/26/18
05/26
10:48
05/26/18
10:48
Periodicals
Micron can solve low valuation, Barron's says »

Micron's stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 20

    Jun

ATUS

Altice USA

$18.50

-0.05 (-0.27%)

10:40
05/26/18
05/26
10:40
05/26/18
10:40
Periodicals
Altice's spinoff could be winning bet, Barron's says »

On June 8, Altice will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 30

    May

MU

Micron

$61.33

-0.15 (-0.24%)

, XLNX

Xilinx

$69.63

0.88 (1.28%)

10:35
05/26/18
05/26
10:35
05/26/18
10:35
Periodicals
AI revolution just getting started, Barron's says »

Artificial Intelligence…

MU

Micron

$61.33

-0.15 (-0.24%)

XLNX

Xilinx

$69.63

0.88 (1.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 20

    Jun

ZTCOY

ZTE Corp.

$0.00

(0.00%)

, DDAIF

Daimler AG

$0.00

(0.00%)

08:08
05/26/18
05/26
08:08
05/26/18
08:08
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

ZTCOY

ZTE Corp.

$0.00

(0.00%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$21.82

-0.445 (-2.00%)

HMC

Honda

$32.04

-0.34 (-1.05%)

NSANY

Nissan

$0.00

(0.00%)

F

Ford

$11.51

-0.11 (-0.95%)

GM

General Motors

$38.30

-0.09 (-0.23%)

TM

Toyota

$129.97

-2.47 (-1.87%)

VLKAY

Volkswagen

$0.00

(0.00%)

BAC

Bank of America

$30.16

-0.03 (-0.10%)

C

Citi

$68.42

-0.86 (-1.24%)

GS

Goldman Sachs

$235.05

-1.1 (-0.47%)

JPM

JPMorgan

$110.62

-0.64 (-0.58%)

MS

Morgan Stanley

$53.02

-0.96 (-1.78%)

USB

U.S. Bancorp

$50.54

-0.14 (-0.28%)

WFC

Wells Fargo

$54.91

0.25 (0.46%)

TWTR

Twitter

$33.64

0.11 (0.33%)

AA

Alcoa

$47.92

-1.26 (-2.56%)

CENX

Century Aluminum

$16.27

-0.07 (-0.43%)

AOBC

American Outdoor Brands

$12.53

0.05 (0.40%)

RGR

Sturm, Ruger

$63.10

0.5 (0.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 30

    May

  • 01

    Jun

  • 06

    Jun

  • 20

    Jun

  • 22

    Jun

  • 13

    Jul

  • 27

    Jul

  • 10

    Sep

  • 12

    Oct

  • 14

    Jan

  • 15

    Apr

  • 15

    Jul

  • 15

    Oct

HCLP

Hi-Crush Partners

$13.20

-0.825 (-5.88%)

17:54
05/25/18
05/25
17:54
05/25/18
17:54
Hot Stocks
Hi-Crush Partners provides update on bulldozer incident in Whitehall facility »

Hi-Crush Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POST

Post Holdings

$77.98

1.49 (1.95%)

17:37
05/25/18
05/25
17:37
05/25/18
17:37
Hot Stocks
Post Holdings reports fire in Michael Foods' plant in Pennsylvania »

Post Holdings reported a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

ABMD

Abiomed

$394.49

0.04 (0.01%)

, WYN

Wyndham

$107.98

-0.58 (-0.53%)

17:34
05/25/18
05/25
17:34
05/25/18
17:34
Hot Stocks
Abiomed to enter S&P 500 index on May 31 »

S&P MidCap 400…

ABMD

Abiomed

$394.49

0.04 (0.01%)

WYN

Wyndham

$107.98

-0.58 (-0.53%)

MSCC

Microsemi

$68.74

0.005 (0.01%)

PRAH

PRA Health

$81.19

0.33 (0.41%)

GME

GameStop

$12.64

-0.1 (-0.78%)

FRED

Fred's

$1.69

0.05 (3.05%)

PRSP

Symbol now PB

$0.00

(0.00%)

RRTS

Roadrunner

$2.19

0.04 (1.86%)

DXC

DXC Technology

$94.20

-5.42 (-5.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 05

    Jun

  • 12

    Jun

PRAH

PRA Health

$81.19

0.33 (0.41%)

, ABMD

Abiomed

$394.49

0.04 (0.01%)

17:24
05/25/18
05/25
17:24
05/25/18
17:24
Hot Stocks
Breaking Hot Stocks news story on PRA Health, Abiomed »

PRA Health to replace…

PRAH

PRA Health

$81.19

0.33 (0.41%)

ABMD

Abiomed

$394.49

0.04 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 05

    Jun

  • 12

    Jun

WYN

Wyndham

$107.98

-0.58 (-0.53%)

, MSCC

Microsemi

$68.74

0.005 (0.01%)

17:23
05/25/18
05/25
17:23
05/25/18
17:23
Hot Stocks
Breaking Hot Stocks news story on Wyndham, Microsemi »

Wyndham to replace…

WYN

Wyndham

$107.98

-0.58 (-0.53%)

MSCC

Microsemi

$68.74

0.005 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABMD

Abiomed

$394.49

0.04 (0.01%)

, WYN

Wyndham

$107.98

-0.58 (-0.53%)

17:21
05/25/18
05/25
17:21
05/25/18
17:21
Hot Stocks
Breaking Hot Stocks news story on Abiomed, Wyndham »

ABIOMED to replace…

ABMD

Abiomed

$394.49

0.04 (0.01%)

WYN

Wyndham

$107.98

-0.58 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 05

    Jun

  • 12

    Jun

PCG

PG&E

$44.67

0.84 (1.92%)

17:16
05/25/18
05/25
17:16
05/25/18
17:16
Periodicals
CA Forestry Dept rules PG&E equipment responsible for wildfires, Bloomberg says »

Report filed by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FARM

Farmer Bros.

$28.50

0.15 (0.53%)

17:09
05/25/18
05/25
17:09
05/25/18
17:09
Hot Stocks
Levin Capital Strategies reports 8.4% stake in Farmer Bros »

Levin Capital purchased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDLS

Noodles & Company

$8.90

-0.35 (-3.78%)

17:07
05/25/18
05/25
17:07
05/25/18
17:07
Syndicate
Breaking Syndicate news story on Noodles & Company »

Noodles & Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$1.22

-0.125 (-9.29%)

17:06
05/25/18
05/25
17:06
05/25/18
17:06
Hot Stocks
Windstream completes one-for-five reverse stock split »

Windstream completed its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDLS

Noodles & Company

$8.90

-0.35 (-3.78%)

17:06
05/25/18
05/25
17:06
05/25/18
17:06
Syndicate
Breaking Syndicate news story on Noodles & Company »

Noodles & Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPD

Enterprise Products

$27.87

-0.12 (-0.43%)

17:01
05/25/18
05/25
17:01
05/25/18
17:01
Hot Stocks
Enterprise Products conduts open season for West Texas Crude oil expansion »

Enterprise Products…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INO

Inovio

$4.89

0.06 (1.24%)

16:37
05/25/18
05/25
16:37
05/25/18
16:37
Syndicate
Breaking Syndicate news story on Inovio »

Inovio files $250M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$10.14

0.13 (1.30%)

16:36
05/25/18
05/25
16:36
05/25/18
16:36
Hot Stocks
Rent-A-Center 16.8% shareholder Engaged Capital nominates Carol McFate to Board »

On May 25, 2018, Engaged…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKER

Akers Biosciences

$0.59

0.0086 (1.48%)

16:34
05/25/18
05/25
16:34
05/25/18
16:34
Hot Stocks
Akers Biosciences receives delinquency notice from NASDAQ »

Akers Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHCP

Ditech

$6.60

0.37 (5.94%)

16:31
05/25/18
05/25
16:31
05/25/18
16:31
Hot Stocks
Ditech discloses receipt of late filing notice from NYSE »

Ditech Holding announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPS

Gap

$28.15

-4.82 (-14.62%)

, FL

Foot Locker

$55.97

9.585 (20.67%)

16:30
05/25/18
05/25
16:30
05/25/18
16:30
General news
On The Fly: Top stock stories for Friday »

Stocks on Wall Street…

GPS

Gap

$28.15

-4.82 (-14.62%)

FL

Foot Locker

$55.97

9.585 (20.67%)

HLF

Herbalife Nutrition

$48.76

-5.09 (-9.45%)

IEP

Icahn Enterprises

$69.41

0.22 (0.32%)

FCAU

Fiat Chrysler

$21.82

-0.445 (-2.00%)

DGX

Quest Diagnostics

$105.89

5 (4.96%)

UNH

UnitedHealth

$244.96

2.23 (0.92%)

ROST

Ross Stores

$77.35

-5.6 (-6.75%)

ADSK

Autodesk

$132.80

-5.96 (-4.30%)

AAL

American Airlines

$44.89

1.34 (3.08%)

LUV

Southwest

$52.86

1.65 (3.22%)

DAL

Delta Air Lines

$55.89

1.48 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 30

    May

  • 30

    May

  • 12

    Jun

  • 13

    Jun

  • 14

    Jun

  • 26

    Jun

  • 29

    Jun

16:30
05/25/18
05/25
16:30
05/25/18
16:30
Options
Preliminary option volume of 16.4M today »

Preliminary option volume…

VTL

Vital Therapies

$5.65

-0.475 (-7.76%)

16:26
05/25/18
05/25
16:26
05/25/18
16:26
Syndicate
Breaking Syndicate news story on Vital Therapies »

Vital Therapies files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.